Elevated C-reactive protein and self-reported disease activity in systemic lupus erythematosus

Lupus

Volumn 23, Issue 14, 2014, Pages 1460-1467

  Eudy, A M ^a   Vines, A I ^a   Dooley, M A ^b   Cooper, G S ^c   Parks, C G ^d  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

C reactive protein; flares; socioeconomic factors; Systemic lupus erythematosus

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AFRICAN AMERICAN; ARTHRITIS; ARTICLE; CAUCASIAN; COHORT ANALYSIS; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; DISEASE ASSOCIATION; DISEASE EXACERBATION; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SECONDARY ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; ETHNOLOGY; METABOLISM; MIDDLE AGED; SELF REPORT; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADULT; AFRICAN AMERICANS; C-REACTIVE PROTEIN; EDUCATIONAL STATUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SELF REPORT; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84911015687     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314543915     Document Type: Article

References (36)

1. Barnes EV, Narain S, Naranjo A, et al. High sensitivity C-reactive protein in systemic lupus erythematosus: Relation to disease activity, clinical presentation and implications for cardiovascular risk. Lupus. 2005 ; 14: 576-582
2. Williams RC, Harmon ME, Burlingame R, Du Clos TW. Studies of serum C-reactive protein in systemic lupus erythematosus. J Rheumatol. 2005 ; 32: 454-461
3. Firooz N, Albert D, Wallace D, Ishimori M, Berel D, Weisman M. High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus. Lupus. 2011 ; 20: 588-597
4. Morrow W, Isenberg D, Parry H, Snaith M. C-reactive protein in sera from patients with systemic lupus erythematosus. J Rheumatol. 1981 ; 8: 599-604
5. Mallya R, de Beer F, Berry H, Hamilton E, Mace B, Pepys M. Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate. J Rheumatol. 1982 ; 9: 224-228
6. Plant MJ, Williams AL, O'Sullivan MM, Lewis PA, Coles EC, Jessop JD. Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis. Arthritis Rheum. 2000 ; 43: 1473-1477
7. Dixon JS, Bird HA, Sitton NG, Pickup ME, Wright V. C-reactive protein in the serial assessment of disease activity in rheumatoid arthritis. Scand J Rheumatol. 1984 ; 13: 39-44
8. Lee S-S, Singh S, Magder L, Petri M. Predictors of high sensitivity C-reactive protein levels in patients with systemic lupus erythematosus. Lupus. 2008 ; 17: 114-123
9. Ford ES, Giles WH, Mokdad AH, Myers GL. Distribution and correlates of C-reactive protein concentrations among adult US women. Clin Chem. 2004 ; 50: 574-581
10. Khera A, McGuire DK, Murphy SA, et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol. 2005 ; 46: 464-469
11. Alarcon GS, Calvo-Alen J. Systemic lupus erythematosus and ethnicity: Nature versus nurture or nature and nurture?. Expert Rev Clin Immunol. 2007 ; 3: 589-601
12. Cooper GS, Treadwell EL, St Clair EW, Gilkeson GS, Dooley MA. Sociodemographic associations with early disease damage in patients with systemic lupus erythematosus. Arthritis Care Res. 2007 ; 57: 993-999
13. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277
14. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
15. Parks CG, Cooper GS, Nylander-rench LA, et al. Occupational exposure to crystalline silica and risk of systemic lupus erythematosus: A population-based, case-control study in the Southeastern United States. Arthritis Rheum. 2002 ; 46: 1840-1850
16. Szalai A, McCrory M, Cooper G, Wu J, Kimberly R. Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene. Genes Immun. 2002 ; 3: 14-19
17. Cooper GS, Parks CG, Treadwell EL, et al. Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States. Lupus. 2002 ; 11: 161-167
18. Karlson EW, Daltroy LH, Rivest C, et al. Validation of a systemic lupus activity questionnaire (SLAQ) for population studies. Lupus. 2003 ; 12: 280-286
19. Yazdany J, Yelin EH, Panopalis P, Trupin L, Julian L, Katz PP. Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort. Arthritis Care Res. 2008 ; 59: 136-143
20. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996 ; 39: 363-369
21. Kushner I, Rzewnicki D, Samols D. What does minor elevation of C-reactive protein signify?. Am J Med. 2006 ; 119: 166.e17 -.e28
22. Adler NE, Newman K. Socioeconomic disparities in health: Pathways and policies. Health Aff. 2002 ; 21: 60-76
23. Laaksonen M, Rahkonen O, Martikainen P, Lahelma E. Socioeconomic position and self-rated health: The contribution of childhood socioeconomic circumstances, adult socioeconomic status, and material resources. Am J Public Health. 2005 ; 95: 1403-1409
24. Kaufman JS, Cooper RS, McGee DL. Socioeconomic status and health in Blacks and Whites: The problem of residual confounding and the resiliency of race. Epidemiology. 1997 ; 8: 621-628
25. Bertoli A, Vila LM, Reveille JD, Alarcon GS. Systemic Lupus Erythematosus in a Multiethnic US Cohort (LUMINA): LXI. Value of C-reactive protein as a marker of disease activity and damage. J Rheumatol. 2008 ; 35: 2355-2358
26. McDade TW, Hawkley LC, Cacioppo JT. Psychosocial and behavioral predictors of inflammation in middle-aged and older adults: The Chicago Health, Aging, and Social Relations Study. Psychosom Med. 2006 ; 68: 376-381
27. Fuligni AJ, Telzer EH, Bower J, Cole SW, Kiang L, Irwin MR. A preliminary study of daily interpersonal stress and C-reactive protein levels among adolescents from Latin American and European backgrounds. Psychosom Med. 2009 ; 71: 329-333
28. Borders AEB, Grobman WA, Amsden LB, McDade TW, Sharp LK, Holl JL. The relationship between self-report and biomarkers of stress in low-income reproductive-age women. Am J Obstet Gynecol. 2010 ; 203: 577.e1-577.e8
29. Adams SG, Dammers PM, Saia TL, Brantley PJ, Gaydos GR. Stress, depression, and anxiety predict average symptom severity and daily symptom fluctuation in systemic lupus erythematosus. J Behav Med. 1994 ; 17: 459-477
30. Fernández M, Alarcón GS, Calvo-alén J, et al. A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Care Res. 2007 ; 57: 576-584
31. ter Borg E, Horst G, Limburg P, van Rijswijk M, Kallenberg C. C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: A prospective longitudinal study. J Rheumatol. 1990 ; 17: 1642-1648
32. Alarcón GS, McGwin G, Brooks K, et al. Systemic lupus erythematosus in three ethnic groups. XI. Sources of discrepancy in perception of disease activity: A comparison of physician and patient visual analog scale scores. Arthritis Care Res. 2002 ; 47: 408-413
33. Neville C, Clarke AE, Joseph L, Belisle P, Ferland D, Fortin PR. Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity. J Rheumatol. 2000 ; 27: 675-679
34. Leong K, Chong E, Kong K, et al. Discordant assessment of lupus activity between patients and their physicians: The Singapore experience. Lupus. 2010 ; 19: 100-106
35. Yen JC, Abrahamowicz M, Dobkin PL, Clarke AE, Battista RN, Fortin PR. Determinants of discordance between patients and physicians in their assessment of lupus disease activity. J Rheumatol. 2003 ; 30: 1967-1976
36. Stoll T, Sutcliffe N, Mach J, Klaghofer R, Isenberg DA. Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus - a 5-yr prospective study. Rheumatology. 2004 ; 43: 1039-1044